The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer and borderline pancreatic inoperable cancers.
 
Ravi Kumar Paluri
Honoraria - Amgen; Ipsen
Speakers' Bureau - Ipsen
 
Upender Manne
No Relationships to Disclose
 
Sushanth Reddy
No Relationships to Disclose
 
James Posey
Consulting or Advisory Role - Lilly
 
Grant Richard Williams
Honoraria - Cardinal Health; Carevive Systems
 
Olumide B. Gbolahan
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Exelixis; Incyte; Merck Sharp & Dohme; QED Therapeutics
Speakers' Bureau - OncLive/MJH Life Sciences
Research Funding - AstraZeneca/MedImmune (Inst)
 
Sejong Bae
No Relationships to Disclose
 
Rojymon Jacob
No Relationships to Disclose